Stay updated on CPX-351 and Ivosidenib in IDH1 AML Clinical Trial

Sign up to get notified when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The website footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-02T16:26:05.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.6%
    Check dated 2026-10-26T16:51:19.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T21:55:48.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-13T04:26:33.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new 'Find contact information' label was added to the page to aid users in locating contact details. The site revision line was updated to Revision: v3.7.0, replacing the previous version.
    Difference
    0.2%
    Check dated 2026-09-21T22:24:01.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The study history was updated to record the latest revision (v3.6.6) and a new Study Status entry on 2026-08-25, superseding the previous revision (v3.6.5).
    Difference
    0.4%
    Check dated 2026-08-31T17:21:30.000Z thumbnail image

Stay in the know with updates to CPX-351 and Ivosidenib in IDH1 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.